In a recent study, recurrence‐free survival (RFS) of patients with postoperatively normalized CEA was shown to be similar to that of patients with normal preoperative CEA,9 suggesting that perioperative change in CEA, rather than preoperative level of CEA, is important in predicting prognosis in colon cancer. The gene discussed is CEACAM5; the disease is colonic neoplasm.